NasdaqCM - Delayed Quote
USD
Polyrizon Ltd. (PLRZ)
10.75
+1.75
(+19.40%)
At close: October 30 at 4:00:01 PM EDT
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Tomer Izraeli
|
Founder, CEO & Director | 365.5k | -- | 1978 |
|
Mr. Nir Ben Yosef
|
CFO & Compliance Officer | 129k | -- | 1975 |
|
Dr. Tidhar Turgeman
|
Chief Technology Officer | 270k | -- | 1976 |
|
Dr. Eyal S. Ron Ph.D.
|
Chief Scientific Officer | -- | -- | 1955 |
Polyrizon Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Corporate Governance
Polyrizon Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
